The HealthTech For Care endowment fund  is designed to support and promote access to care for all and, more specifically, to new medical technologies and drugs. The initiatives and events of the fund with a European dimension will bring together all the actors involved in the medical innovation value chain allowing better coordination within the European health ecosystem. In this context, the HealthTech Innovation Days (HTID®) event will be held in Paris on October 5 & 6.

The missions of the endowment fund are structured around three main areas:

1. Support the development of the entire health ecosystem by:

Contributing to a better coordination and understanding

Contributing to a better coordination and understanding of the practices of health professionals in the interest of patients and medical research

Supporting actions

Supporting actions relating to the creation of a local, national and international ecosystem of organized care pathways

Supporting programs and actions

Supporting programs and actions that promote innovation and medical progress

Stimulating the financing of innovation

Stimulating the financing of the development and access to innovative therapies and treatments.

Stimulating funding

Stimulating the funding of dedicated research programs

2. Support the development of innovative therapies and treatments by:

3. Promote better access to healthcare for patients in the French health ecosystem and more widely throughout Europe by:

Supporting patients' associations

Supporting patients' associations, by organizing meetings dedicated to improving the state of related research between the various players in the health ecosystem.

Promoting the exchange of information

Promoting the exchange and dissemination of information on innovative therapies, treatments and therapeutic approaches ;

The HealthTech For Care fund was founded by France Biotech; Maryvonne Hiance, VP and co-founder of OSE Immunotherapeutics; and several key industry leaders; and will foster access to innovative healthcare solutions for all patients through the organization of Europe-focused initiatives and events. These events will bring together academic researchers, entrepreneurs, manufacturers and leaders in the commercialization of new medical technologies and treatments. 
« More than ever, we are aware that access to medical innovation for all patients is a major economic and societal challenge. To address this, we have created HealthTech For Care, which puts the interests of patients first. We are convinced that the quality of interactions between key industry players is a determining factor in accelerating the transition from research to market and enabling faster access for all patients to new medical solutions,” said Maryvonne Hiance, President of HealthTech For Care.
Thus, the approach of HealthTech For Care involves the decompartmentalization of the medical ecosystem, research departments, companies developing new technologies, pharmaceutical companies, patient associations and public and private investors.

For more information please contact us:

Nathalie Donne nathalie.donne@shapenlink.com
Estelle Metzger estelle.metzger@france-biotech.org 
Marion Garbay marion.garbay@france-biotech.org

HealthTech For Care, 24 bd du Montparnasse 75015 Paris, France